National Vision Beats Q2 Street View, Sees FY23 EPS To Be At Or Above Guided Outlook Midpoint
National Vision Holdings Inc (NASDAQ: EYE) reported Q2 net revenue growth of 3.1% Y/Y to $525.3 million, slightly
International Seaways Tops Q2 Estimates On Strong TCE Revenues
International Seaways Inc (NYSE: INSW) reported a Q2 FY23 shipping revenue of $292.2 million, up from $188.2 million a year ago, beating the
Why Fortinet Shares Are Tumbling Today
Fortinet Inc (NASDAQ: FTNT) shares are trading lower by around 20% after it reported Q2 FY23 earnings results and
Why Microchip Technology Shares Are Diving Today
Microchip Technology Inc (NASDAQ: MCHP) shares are trading lower by around 6% after the company reported
Missfresh Announces Entry Of Share Purchase Agreements For Financing And Business Acquisition; Investors Agree To Subscribe 5.4B Class B Ordinary Shares Of The Company In Aggregate For A Total Purchase Price Of $27
Missfresh Limited ("Missfresh" or the "Company") (NASDAQ:MF), today announced that it entered into two share purchase agreements with two investors, respectively (the "Share Purchase Agreements
PCB Bancorp Announces Stock Repurchase Program Of Up To 720K Shares Of Common Stock, ~7% Expiring On August 2, 2024
PCB Bancorp (the "Company") (NASDAQ:PCB), the holding company of PCB Bank, announced that on August 2, 2023, its Board of Directors approved a stock repurchase program authorizing the repurchase of up to 720,000 shares
Hilton Grand Vacations Posts Mixed Q2 Results, Reaffirms FY23 Outlook
Hilton Grand Vacations Inc (NYSE: HGV) reported Q2 FY23 revenues of $1.007 billion, missing the
Why DXC Technology Shares Are Diving Today
DXC Technology Co (NYSE: DXC) shares are trading lower by around 20% after it reported worse-than-expected Q1 FY24 results and issued a
Equillium Announces $7.5M Share Repurchase Program
Equillium, Inc. (NASDAQ:EQ), a clinical-stage biotechnology company leveraging a deep understanding of immunobiology to develop novel therapeutics to treat severe autoimmune and inflammatory disorders, today
DuPont Beats Q2 Earnings Estimates, Revises FY23 Outlook
DuPont De Nemours, Inc. (NYSE: DD) reported a Q2 FY23 sales decrease of 7% Y/Y to $3.09 billion, beating